title: Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration, denervation and muscular dystrophy.
abstract: Human IGF-I was over-expressed in skeletal muscles of C57/BL6xCBA mice under the control of the rat skeletal alpha-actin gene promoter. RT-PCR verified expression of the transgene in skeletal muscle but not in the liver of 1- and 21-day old heterozygote transgenic mice. The concentration of endogenous mouse IGF-I, measured by an immunoassay which does not detect human IGF-I, was not significantly different between transgenic mice and wild-type littermates (9.5 +/- 0.8 and 13.3 +/- 1.9 ng/g in muscle; 158.3 +/- 18.6 and 132.9 +/- 33.1 ng/ml in plasma, respectively). In contrast, quantitation with antibodies to human IGF-I showed an increase in IGF-I of about 100 ng/ml in plasma and 150 ng/g in muscle of transgenic mice at 6 months of age. Transgenic males, compared to their age matched wild-type littermates, had a significantly higher body weight (38.6 +/- 0.53 g vs. 35.8 +/- 0.64 g at 6 months of age; P < 0.001), dry fat-free carcass mass (5.51 +/- 0.085 vs. 5.08 +/- 0.092 g; P < 0.001) and myofibrillar protein mass (1.62 +/- 0.045 vs. 1.49 +/- 0.048 g; P < 0.05), although the fractional content of fat in the carcass was lower (167 +/- 7.0 vs. 197 +/- 7.7 g/kg wet weight) in transgenic animals. There was no evidence of muscle hypertrophy and no change in the proportion of slow type I myofibres in the limb muscles of Rskalpha-actin/hIGF-I transgenic mice at 3 or 6 months of age. Phenotypic changes in Rskalpha-actin/hIGF-I mice are likely to be due to systemic as well as autocrine/paracrine effects of overproduction of IGF-I due to expression of the human IGF-I transgene. The effect of muscle specific over-expression of Rskalpha-actin/hIGF-I transgene was tested on: (i) muscle regeneration in auto-transplanted whole muscle grafts; (ii) myofibre atrophy following sciatic nerve transection; and (iii) sarolemmal damage and myofibre necrosis in dystrophic mdx muscle. No beneficial effect of muscle specific over-expression of Rskalpha-actin/hIGF-I transgene was seen in these three experimental models.
authors.affiliation: School of Anatomy and Human Biology, The University of Western Australia, Crawley, Perth. sthea@anhb.uwa.edu.au
authors.forename: T
authors.initials: T
authors.lastname: Shavlakadze
authors.forename: J M
authors.initials: JM
authors.lastname: Boswell
authors.forename: D W
authors.initials: DW
authors.lastname: Burt
authors.forename: E A
authors.initials: EA
authors.lastname: Asante
authors.forename: F M
authors.initials: FM
authors.lastname: Tomas
authors.forename: M J
authors.initials: MJ
authors.lastname: Davies
authors.forename: J D
authors.initials: JD
authors.lastname: White
authors.forename: M D
authors.initials: MD
authors.lastname: Grounds
authors.forename: C
authors.initials: C
authors.lastname: Goddard
mesh_terms: D000199:Actins / Q000235:genetics; D000818:Animals; D001835:Body Weight; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009121:Muscle Denervation; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D009136:Muscular Dystrophies / Q000235:genetics* / Q000473:pathology; D011401:Promoter Regions, Genetic; D051381:Rats; D012038:Regeneration / Q000235:genetics*; D015533:Transcriptional Activation
chemical_list: D000199:Actins; D007334:Insulin-Like Growth Factor I